Skip to content

Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer

Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer in a Low Volume Center

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04481828
Enrollment
60
Registered
2020-07-22
Start date
2014-01-31
Completion date
2020-01-31
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

In gastric cancer, laparoscopic gastrectomy is commonly performed in Asian countries. In other regions where tumor incidence is relatively low and patient characteristics are different, developments in this issue have been limited. In this study, the investigators aimed to compare the early results for patients who underwent open or laparoscopic gastrectomy for gastric cancer in a center in Turkey.

Detailed description

The patients who were operated in Kocaeli Derince Training and Research Hospital between January 2014 and January 2019 consecutively due to gastric cancer were analyzed. The diagnosis was made by upper gastrointestinal endoscopy and endoscopic biopsy. Clinical staging was done using contrast computed tomography (CT). Positron emission tomography (PET) was used in patients with suspected metastasis.The patients were divided into two groups according to the technique applied (open, laparotomy). The first group (Group 1; n: 30) consisted of patients who underwent open surgery, and the second group (Group 2, n: 30) laparoscopic surgery.

Interventions

PROCEDUREgastrectomy

gastric resection with lymph node dissection(D1+,D2) for stomach cancer.

Sponsors

Kocaeli Derince Education and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Gastric cancer(adenocarcinoma) proven biopsy * Operated by same surgical team * Presence of distant metastasis

Exclusion criteria

* Patients who underwent palliative resection * operated by a different surgical team * ASA score: 4

Design outcomes

Primary

MeasureTime frameDescription
Age2014-2019year
Body mass index2014- 2019kg/m2
Previous abdominal surgery status2014-2019yes or no
Comorbidity status2014 -2019present or absent
Neoadjuvant therapy status2014-2019present or absent
American Society of Anesthesiologists (ASA) score2014-20191,2,3,4
Gender2014-2019male or female
Surgical technique2014-2019open or laparoscopic
Tumor localization2014 - 2019proximal, middle, lower
Gastrectomy type2014 - 2019total, subtotal
Lymph node dissection type2014 - 2019D1+, D2
Operation time2014 - 2019minute
Blood loss2014 - 2019ml
Complication (Clavien-Dindo Classification)2014 - 20191,2,3 A,3 B,4 A,4 B,5 (according to Clavien-Dindo Classification)
30-day mortality2014 - 2019present or absent
Number of harvested lymph node2014 - 2019number
Resection margin status2014 - 2019positive or negative
Tumor stage (American Joint Committee on Cancer 8th Edition)2014 - 20190,1,2 A,2 B,3,4 A, 4 B (According to American Joint Committee on Cancer 8th Edition)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026